Response to Dr. Norman W. Baylor's Letter to the Editor entitled: "Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax"

Michael N. Oxman, Anne A. Gershon, Gregory A. Poland

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)8772
Number of pages1
Issue number48
StatePublished - Nov 8 2011

ASJC Scopus subject areas

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this